ETSY Gears Up to Report Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2262641/etsy-gears-up-to-report-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2262641
Apr 25, 2024 - ETSY's first-quarter 2024 earnings are likely to have gained from growing momentum among active buyers and active sellers.
0
Neurocrine launches CAH community website ahead of FDA filing
https://seekingalpha.com/news/4093768-neurocrine-launches-cah-community-website-ahead-of-fda-filing?source=feed_sector_healthcare
Apr 24, 2024 - Neurocrine (NBIX), which has developed a drug for congenital adrenal hyperplasia, has launched a new interactive website to support patients with the condition. Read more here.
0
What's in Store for NXP Semiconductors' (NXPI) Q1 Earnings?
https://www.zacks.com/stock/news/2261539/what-s-in-store-for-nxp-semiconductors-nxpi-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2261539
Apr 24, 2024 - NXP Semiconductors' (NXPI) first-quarter results will likely reflect strength across Industrial & IoT and Mobile end markets. However, weakening demand in the Automotive segment may have been a concern.
0
What's in Store for STMicroelectronics (STM) in Q1 Earnings?
https://www.zacks.com/stock/news/2260523/what-s-in-store-for-stmicroelectronics-stm-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2260523
Apr 23, 2024 - STMicroelectronics' (STM) first-quarter results are expected to reflect strength in the automotive market. However, weakening demand across the personal electronics market is a concern.
0
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
https://www.zacks.com/stock/news/2259368/is-a-beat-likely-for-west-pharmaceutical-wst-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259368
Apr 22, 2024 - West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
0
Lam Research (LRCX) to Post Q3 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2258614/lam-research-lrcx-to-post-q3-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258614
Apr 19, 2024 - Lam Research's (LRCX) third-quarter fiscal 2024 results are expected to reflect strength in 3D DRAM and advanced packaging amid a slowdown in memory spending.
0
What's in Store for Texas Instruments (TXN) in Q1 Earnings?
https://www.zacks.com/stock/news/2257973/what-s-in-store-for-texas-instruments-txn-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257973
Apr 18, 2024 - Texas Instruments' (TXN) first-quarter 2024 results are likely to reflect the adverse impacts of inventory reduction and macro headwinds.
0
Here's Why You Should Retain Medtronic (MDT) Stock for Now
https://www.zacks.com/stock/news/2257854/here-s-why-you-should-retain-medtronic-mdt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2257854
Apr 18, 2024 - Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
0
IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA
https://www.zacks.com/stock/news/2257851/icecure-medical-iccm-submits-final-cryoablation-data-to-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2257851
Apr 18, 2024 - IceCure Medical (ICCM) submits final ICE data along with multiple sub-analysis to the FDA seeking approval for marketing authorization for treating early-stage breast cancer.
0
Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay
https://www.zacks.com/stock/news/2257016/henry-schein-hsic-global-presence-aids-macroeconomic-woes-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2257016
Apr 17, 2024 - Henry Schein (HSIC) is busy promoting digital workflows for general dentistry and dental specialties.
0
Page 1>